首页> 外文学位 >Structural dynamics of G protein-coupled receptor monomers and oligomers: Insights from the beta2-adrenergic receptor.
【24h】

Structural dynamics of G protein-coupled receptor monomers and oligomers: Insights from the beta2-adrenergic receptor.

机译:G蛋白偶联受体单体和寡聚体的结构动力学:β2-肾上腺素能受体的见解。

获取原文
获取原文并翻译 | 示例

摘要

Using a prototypical GPCR, the beta2-adrenergic receptor (beta2AR), we studied various aspects of receptor monomeric structure and dynamics, as well as studies to understand the mechanisms of receptor oligomerization.;In our initial experiments using purified, monomeric beta2AR, we generated several mutants to address structural aspects of the C-terminus using Fluorescence Resonance Energy Transfer (FRET). The C-terminus plays a role in ligand-dependent protein-protein interactions such as arrestin desensitization/signaling and phosphorylation by GRK. Thus, we introduced tetracysteine motifs (CCPGCC) at the proximal C-terminus (from residues 351-356) or distal C-terminus (starting at the last residue 413) that are capable of specifically binding to Fluoresceine Arsenical Helix binders (FlAsH), the donor fluorophore for our intramolecular FRET studies.;Immunization of mice with beta2AR in liposomes resulted in the production of nine monoclonal antibodies, five which bound the intracellular domain of the receptor and four that bound the extracellular domain. Only two of the nine monoclonal antibodies (Ab 5 and Ab 9) were able to recognize a 3-dimensional epitope as assessed by immunoblotting to denatured beta 2AR. Because Ab 5 also recognized an intracellular 3-dimensional epitope, it was chosen to generate Fabs for crystal trials of the beta2AR. Vapor phase diffusion, using ammonium sulfate as the precipitant, resulted in diffraction quality crystals of Fab 5 complexed to the beta2AR (beta2AR-Fab5). Optimization of the crystallizing conditions resulted in a subsequent high-resolution structure (3.4 A) of monomeric beta 2AR bound to an inverse agonist, the first for a GPCR activated by a diffusible ligand.;We developed methods for studying the quaternary structure of purified beta 2AR to understand oligomeric structural aspects of this prototypical GPCR. Using a minimal cysteine beta2AR construct (Delta5-beta 2AR), three single-reactive cysteine mutants were generated for FRET studies: T66C (Delta5-beta2AR-T66C) in intracellular loop 1 (ICL1); A265C (Delta5-beta2AR-A265C) at the base of TM6; and R333C (Delta5-beta2AR-R333C) in helix 8 (H8). Using these three beta 2AR mutants, we could obtain maximal spatial distribution from our donor (Cy3-maleimide) and acceptor (Cy5-maleimide) fluorophores as well as infer into the orientation of protomers in an oligomeric assembly using FRET. Reconstitution of these purified receptors into a model DOPC/cholesterol hemisuccinate lipid bilayer yielded an even distribution of fully functional receptors in vesicles, mostly in an outside-out orientation as determined by four independent biochemical techniques. Intermolecular FRET analysis revealed that the beta2AR forms specifically oriented oligomers upon reconstitution into a lipid bilayer, independent of other cellular proteins and that TM6-TM6 interactions are the furthest from the regions investigated. Overcrowding the lipid vesicle membrane with receptors was not the cause of FRET since reconstitution with a 10-fold higher lipid-to-receptor ratio resulted in insignificant changes in FRET. Furthermore, saturation FRET experiments were used in order to address the specificity of interactions. It follows that if two proteins have an affinity for one another, a saturable amount of FRET should be observed, whereas randomly colliding proteins will follow a quasi-linear regression. Indeed, all three single-reactive cysteine beta2AR mutants demonstrated saturable amounts of FRET. We then used a mathematical model described previously to generate theoretical FRET saturation curves for dimers, trimers, tetramers and higher-order oligomers. Our experimental results demonstrated that the beta 2AR more closely follows the theoretical curve for a tetramer, suggesting that beta2ARs can form specific tetramers in the absence of other cellular proteins in lipid bilayers. This allowed us to propose a model of a beta2AR tetramer where TM6s are on the periphery of the tetramer, due to the consistently lower FRET in the TM6-TM6 pair.;Taken together, the investigations presented offer an in-depth view of the structural dynamics of a prototypical GPCR, the beta2AR, and provide novel avenues to explore receptor activation and inactivation at the molecular and supramolecular level. (Abstract shortened by UMI.)
机译:我们使用原型GPCRβ2-肾上腺素受体(beta2AR),研究了受体单体结构和动力学的各个方面,以及了解受体低聚机理的研究。在我们使用纯化的单体beta2AR进行的最初实验中,我们生成了使用荧光共振能量转移(FRET)解决C末端结构方面的几个突变体。 C末端在依赖配体的蛋白质-蛋白质相互作用中发挥作用,例如抑制蛋白的脱敏/信号传导和GRK的磷酸化。因此,我们在近端C端(来自残基351-356)或远端C端(从最后一个残基413开始)引入了能够与荧光素砷化螺旋结合剂(FlAsH)结合的四半胱氨酸基序(CCPGCC),我们的分子内FRET研究的供体荧光团。用脂质体中的beta2AR免疫小鼠导致产生9种单克隆抗体,其中5种结合受体的细胞内结构域,而4种结合细胞外结构域。九种单克隆抗体中只有两种(Ab 5和Ab 9)能够识别3维表位,这是通过对变性的β2AR进行免疫印迹来评估的。因为Ab 5还识别细胞内3维表位,所以选择它来生成Fabs用于beta2AR的晶体试验。使用硫酸铵作为沉淀剂的汽相扩散导致Fab 5的衍射质量晶体复合到beta2AR(beta2AR-Fab5)上。结晶条件的优化导致随后的高纯度结构(3.4 A)的单体β2AR与反向激动剂结合,这是可扩散配体激活的GPCR的第一个结构;我们开发了研究纯化β的四级结构的方法。 2AR了解该原型GPCR的寡聚结构方面。使用最小的半胱氨酸beta2AR构建体(Delta5-beta 2AR),生成了三个单反应性半胱氨酸突变体用于FRET研究:细胞内环1(ICL1)中的T66C(Delta5-beta2AR-T66C); TM6底部的A265C(Delta5-beta2AR-A265C);螺旋8(H8)中的R333C和R333C(Delta5-beta2AR-R333C)。使用这三个beta 2AR突变体,我们可以从我们的供体(Cy3-马来酰亚胺)和受体(Cy5-马来酰亚胺)荧光团中获得最大的空间分布,并使用FRET推断寡聚体组装中的启动子方向。将这些纯化的受体重构为模型DOPC /胆固醇半琥珀酸酯脂质双层,可以在囊泡中形成功能齐全的受体的均匀分布,这主要是通过四种独立的生化技术从外到外的方向进行的。分子间FRET分析表明,β2AR重组为脂质双层后,会形成特定方向的寡聚体,而与其他细胞蛋白无关,并且TM6-TM6相互作用距离所研究的区域最远。脂质囊泡膜上的受体过度拥挤并不是FRET的原因,因为以10倍高的脂质与受体比例进行重组导致FRET发生了微不足道的变化。此外,使用饱和FRET实验来解决相互作用的特异性。因此,如果两种蛋白质彼此具有亲和力,则应观察到可饱和的FRET量,而随机碰撞的蛋白质将遵循准线性回归。实际上,所有三个单反应性半胱氨酸beta2AR突变体均显示出可饱和的FRET量。然后,我们使用先前描述的数学模型为二聚体,三聚体,四聚体和高阶低聚物生成理论FRET饱和曲线。我们的实验结果表明,β2AR更接近四聚体的理论曲线,表明在脂质双层中不存在其他细胞蛋白的情况下,β2ARs可以形成特定的四聚体。这使我们能够提出一个beta2AR四聚体的模型,由于TM6-TM6对中FRET始终较低,因此TM6位于四聚体的外围。总而言之,所提供的研究提供了对结构的深入了解GPCRβ2AR的动力学过程,并提供了探索分子和超分子水平受体激活和失活的新途径。 (摘要由UMI缩短。)

著录项

  • 作者

    Fung, Juan Jose.;

  • 作者单位

    Stanford University.;

  • 授予单位 Stanford University.;
  • 学科 Biology Molecular.
  • 学位 Ph.D.
  • 年度 2009
  • 页码 231 p.
  • 总页数 231
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子遗传学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号